392 related articles for article (PubMed ID: 25109834)
21. PGE(2) induces MUC2 and MUC5AC expression in human intrahepatic biliary epithelial cells via EP4/p38MAPK activation.
Yang L; Junmin S; Hong Y; Shuodong W
Ann Hepatol; 2013; 12(3):479-86. PubMed ID: 23619266
[TBL] [Abstract][Full Text] [Related]
22. Prostaglandin E2-induced IL-23p19 subunit is regulated by cAMP-responsive element-binding protein and C/AATT enhancer-binding protein β in bone marrow-derived dendritic cells.
Kocieda VP; Adhikary S; Emig F; Yen JH; Toscano MG; Ganea D
J Biol Chem; 2012 Oct; 287(44):36922-35. PubMed ID: 22977257
[TBL] [Abstract][Full Text] [Related]
23. Prostaglandin E₂ receptor EP1-mediated phosphorylation of focal adhesion kinase enhances cell adhesion and migration in hepatocellular carcinoma cells.
Bai X; Wang J; Zhang L; Ma J; Zhang H; Xia S; Zhang M; Ma X; Guo Y; Rong R; Cheng S; Shu W; Wang Y; Leng J
Int J Oncol; 2013 May; 42(5):1833-41. PubMed ID: 23525457
[TBL] [Abstract][Full Text] [Related]
24. COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation.
Majumder M; Landman E; Liu L; Hess D; Lala PK
Mol Cancer Res; 2015 Jun; 13(6):1022-33. PubMed ID: 25733698
[TBL] [Abstract][Full Text] [Related]
25. CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.
Pannem RR; Dorn C; Ahlqvist K; Bosserhoff AK; Hellerbrand C; Massoumi R
Carcinogenesis; 2014 Feb; 35(2):461-8. PubMed ID: 24104553
[TBL] [Abstract][Full Text] [Related]
26. PGE2 induces IL-1beta gene expression in mouse osteoblasts through a cAMP-PKA signaling pathway.
Park YG; Kang SK; Noh SH; Park KK; Chang YC; Lee YC; Kim CH
Int Immunopharmacol; 2004 Jun; 4(6):779-89. PubMed ID: 15135319
[TBL] [Abstract][Full Text] [Related]
27. PGE2 inhibits chondrocyte differentiation through PKA and PKC signaling.
Li TF; Zuscik MJ; Ionescu AM; Zhang X; Rosier RN; Schwarz EM; Drissi H; O'Keefe RJ
Exp Cell Res; 2004 Oct; 300(1):159-69. PubMed ID: 15383323
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin E(2) promotes cell proliferation via protein kinase C/extracellular signal regulated kinase pathway-dependent induction of c-Myc expression in human esophageal squamous cell carcinoma cells.
Yu L; Wu WK; Li ZJ; Li HT; Wu YC; Cho CH
Int J Cancer; 2009 Dec; 125(11):2540-6. PubMed ID: 19623651
[TBL] [Abstract][Full Text] [Related]
29. Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells.
Bai XM; Jiang H; Ding JX; Peng T; Ma J; Wang YH; Zhang L; Zhang H; Leng J
Life Sci; 2010 Jan; 86(5-6):214-23. PubMed ID: 20035770
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E2 and the protein kinase A pathway mediate arachidonic acid induction of c-fos in human prostate cancer cells.
Chen Y; Hughes-Fulford M
Br J Cancer; 2000 Jun; 82(12):2000-6. PubMed ID: 10864209
[TBL] [Abstract][Full Text] [Related]
31. Focal adhesion kinase: important to prostaglandin E2-mediated adhesion, migration and invasion in hepatocellular carcinoma cells.
Bai XM; Zhang W; Liu NB; Jiang H; Lou KX; Peng T; Ma J; Zhang L; Zhang H; Leng J
Oncol Rep; 2009 Jan; 21(1):129-36. PubMed ID: 19082453
[TBL] [Abstract][Full Text] [Related]
32. The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells.
Cherukuri DP; Chen XB; Goulet AC; Young RN; Han Y; Heimark RL; Regan JW; Meuillet E; Nelson MA
Exp Cell Res; 2007 Aug; 313(14):2969-79. PubMed ID: 17631291
[TBL] [Abstract][Full Text] [Related]
33. Calcium-mediated increased expression of fibroblast growth factor-2 acts through NF-κB and PGE2/EP4 receptor signaling pathways in cementoblasts.
Kanaya S; Nemoto E; Sakisaka Y; Shimauchi H
Bone; 2013 Oct; 56(2):398-405. PubMed ID: 23851295
[TBL] [Abstract][Full Text] [Related]
34. Disruption of prostaglandin E2 receptor EP4 impairs urinary concentration via decreasing aquaporin 2 in renal collecting ducts.
Gao M; Cao R; Du S; Jia X; Zheng S; Huang S; Han Q; Liu J; Zhang X; Miao Y; Kang J; Gustafsson JÅ; Guan Y
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8397-402. PubMed ID: 26100911
[TBL] [Abstract][Full Text] [Related]
35. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.
Robertson FM; Simeone AM; Mazumdar A; Shah AH; McMurray JS; Ghosh S; Cristofanilli M
J Exp Ther Oncol; 2008; 7(4):299-312. PubMed ID: 19227010
[TBL] [Abstract][Full Text] [Related]
36. PGE2-induced hypertrophy of cardiac myocytes involves EP4 receptor-dependent activation of p42/44 MAPK and EGFR transactivation.
Mendez M; LaPointe MC
Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2111-7. PubMed ID: 15626689
[TBL] [Abstract][Full Text] [Related]
37. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones.
Matsumoto S; Ikeda M; Yoshida S; Tanimoto T; Takeda M; Nasu M
Br J Pharmacol; 2005 Jun; 145(4):503-13. PubMed ID: 15821755
[TBL] [Abstract][Full Text] [Related]
38. Molecular cloning and functional characterization of the canine prostaglandin E2 receptor EP4 subtype.
Castleberry TA; Lu B; Smock SL; Owen TA
Prostaglandins Other Lipid Mediat; 2001 Jul; 65(4):167-87. PubMed ID: 11444589
[TBL] [Abstract][Full Text] [Related]
39. Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Signaling Pathways in Human LoVo Colon Cancer Cells.
Hsu HH; Lin YM; Shen CY; Shibu MA; Li SY; Chang SH; Lin CC; Chen RJ; Viswanadha VP; Shih HN; Huang CY
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28587064
[TBL] [Abstract][Full Text] [Related]
40. EP4/EP2 receptor-specific prostaglandin E2 regulation of interleukin-6 generation by human HSB.2 early T cells.
Zeng L; An S; Goetzl EJ
J Pharmacol Exp Ther; 1998 Sep; 286(3):1420-6. PubMed ID: 9732406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]